Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Researchers find the cause of a metabolic disease. New study demonstrates that loss of autophagy enzymes in respiring cells causes a metabolic deficit and cell death due to depletion of NAD.
02 November 2021 Urgent changes needed to global guidelines designed to stop surgical infection Wound infections are the most common problem after surgery, particularly in developing countries, but promised innovations to tackle the issue do not work and global guidance needs changing, a new study reveals.
11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
06 October 2021 One in seven patients miss cancer surgery during COVID lockdowns - study One in seven cancer patients around the world have missed out on potentially life-saving operations during COVID-19 lockdowns, a new study reveals.
04 October 2021 Higher rates of mutation alone are not to blame for age-related disease, study finds Small mutations accumulating in DNA are unlikely to be fully responsible for the ageing process, finds a new study carried out in collaboration with the University of Birmingham.
13 September 2021 Scientists discover new pathway that prevents bowel cancer treatment from working Leading scientists at the University of Birmingham have discovered a previously unknown pathway that prevents specific drugs from working in patients with bowel cancer.
26 August 2021 Global COVID-19 surgery study scoops scientific world record A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration.
26 August 2021 New study to test third COVID-19 vaccine for people with weakened immune systems A new clinical trial has launched in the UK to determine whether a third vaccine will improve the immune response of people who have weakened immune systems.
25 August 2021 Recent COVID-19 infection puts surgical patients at higher blood clot risk Surgical patients who have recently had COVID-19 are more likely to develop potentially fatal post-operative blood clots, a new global study reveals.
24 August 2021 Study shows low or undetectable immune response to double COVID-19 vaccination in patients with impaired immune systems A significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine
18 August 2021 Birmingham researchers confirm speed, simplicity and sensitivity for new COVID-19 test Researchers from the University of Birmingham have confirmed the speed, accuracy and simplicity of a novel, highly sensitive testing method for COVID-19.
10 August 2021 Patients who isolate before surgery are 20% more likely to develop post-operative lung complications, finds study Patients isolating before surgery - mainly to avoid COVID-19 and its complications – are at a 20% increased risk of developing post-operative lung complications compared with patients who do not isolate.
05 August 2021 Genetic study reveals ancient human adaptation to agriculture and climate change in Middle East The most comprehensive study so far of genetic diversity in the Middle East has given a glimpse into the lives of ancient humans who lived through seismic events including the formation of the Arabian Desert.